pulseline logo

New research to tackle Australia’s two biggest killers

[vc_row][vc_column][vc_column_text]The Government’s investment will support innovative, high quality, collaborative research that focuses on prevention, early-intervention, treatment and survivorship of heart disease and stroke.

This round will focus on three priorities:

  • Preventing heart disease and stroke.
  • Improving survival rates after an acute heart or stroke event.
  • Improving survival after a cardiovascular event or stroke and preventing a recurrence.

In 2018, ischaemic heart disease killed 17,533 Australians and cerebrovascular diseases (stroke) killed 9,972 Australians.

However, cardiovascular disease is an area in which Australia can boast strong recent successes, with deaths falling by almost 70 per cent over the past three decades.

Much of this success has been achieved through improvements in the prevention, detection and management of the disease.

The Government has committed to a strong research agenda to find more effective methods for preventing, treating and managing heart conditions and, ideally, a cure.

More than $1.7 billion has been invested in clinical research into cardiovascular disease through National Health and Medical Research Council grants since 2000.

The Government is now investing $220 million from the $20 billion Medical Research Future Fund (MRFF) for the dedicated 10-year Cardiovascular Health Mission.

The Mission aims to improve health outcomes through prevention strategies and earlier detection for patients suffering a heart attack or stroke.

It will support Australian researchers to make game-changing discoveries, develop a global biotech industry and enable the implementation of changes in health care.

Grants open on 13 December 2019 and will be managed by the National Health and Medical Research Council. For more information on how to apply, visit GrantConnect.[/vc_column_text][/vc_column][/vc_row]

Related Stories


You have subscribed